Pediatric rheumatology

Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis

Pediatr Rheumatol Online JPublished Retrospective cohort study

Authors' conclusion

A sizeable proportion of patients treated in the decade preceding the beginning of the "T2T era" and on continued follow-up did not achieve or maintain the state of CID over the long term.

Study context

Population
Juvenile idiopathic arthritis (JIA) patients followed at the study center 2007–2017, first seen within 6 months after disease onset, with ≥6-month follow-up (pre-T2T decade)
Participants
394 patients
Exposure
Systemic vs Oligoarticular vs Polyarticular vs Other arthritis
Outcome
CID (2004 Wallace criteria)
Follow-up
6, 12, 24 and 60 months after first observation
Methodological detailssingle-centre, chart review, cross-sectional assessment at 6, 12, 24 and 60 months
  • Single-centre
  • Chart review
  • Cross-sectional assessment at 6, 12, 24 and 60 months

Main finding

As reported in the abstract

Overall frequency of CID

Clinical inactive disease (CID) at 6 months

25.1%

CID at 12 months

34.5%

CID at 24 months

44.6%

CID at 60 months

49.1%

Observational data: associations, not effects.

Further findings

CID by phenotype among patients still followed at study center · 60 months

OutcomeSystemicOligoarticularPolyarticularOther arthritis
CID by phenotype (highest rates: systemic and oligoarticular subgroups) · 6 months32.1%29.5%— not stated in the abstract— not stated in the abstract
CID by phenotype (highest rates: systemic and oligoarticular subgroups) · 12 months40%41.1%— not stated in the abstract— not stated in the abstract

— not stated in the abstract

  • CID by phenotype among patients still followed at study center: 60-month evaluation available for 226 out of 394 patients (57.4%)

Original publication

Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. Published 23 January 2025. doi:10.1186/s12969-025-01057-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.